51
Views
44
CrossRef citations to date
0
Altmetric
Research Article

Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer

Pages 731-737 | Published online: 03 Jul 2009

  • BARRANCO, S. C. and FLOURNEY, D. R., 1973, Modification of the response to actinomycin-D induced sublethal damage by simultaneous recovery from potentially lethal damage in mammalian cells. Cancer Research, 36, 1634-1640.
  • BARRANCO, S. C., NOVAK, J. K. and HUMPREY, R. M., 1973, Response of mammalian cells following treatment with bleomycin and 1,3-BTS (2 chloroethyl)-l-nitrosourea during plateau phase. Cancer Research, 33, 691-694.
  • BISSERY, M. C., NOHYNEK, G., SANDERINK, G. J. and LAVELLE, F., 1995, Docetaxel (Taxotere): a review of preclinical and clinical experience. Part 1: pre clinical experience. Anti-cancer Drugs, 6, 339-368.
  • BOUKAMP, P., PETRUSSEVSKA, R. T., BREITKREUTZ, D., HORNUNG, J., MARKHAM, A. and FUSENIG, N. E., 1988, Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. Journal of Cell Biology, 106, 761-771.
  • BOUKAMP, P., STANBRIDGE, E. J., Foo, D. Y., CERUTTI, P. A. and FUSENIG, N. E., 1990, C-Ha-ras oncogene expression in immortalised human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Research, 50, 2840-2847.
  • CATIMEL, G., VERWEIJ, J., MATTUSSEN, V., HANAUSKE, A. and KAYE, S. B., 1994, Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. Annals of Oncology, 5, 533-537.
  • CHOY, H., RODRIGUEZ, F., KOESTER, M., HILSENBECK, S. andVON HOFF, D. D., 1993, Investigation of taxol as a potential radiation sensitiser. Cancer, 11, 3774-3778.
  • CHOY, H., RODRIGUEZ, F., WILCOX, B., KOESTER, S. K. and DEGEN, D., 1992, Radiation sensitising effects of taxotere (RP56976). Proceedings of the American Society of Clinical Oncology, 12, 56.
  • COLIN, M., GUENARD, D., GUERITTE-VOEGELEIN, F. and POTIER, P., 1989, Process for the preparation of taxol and 1Odeacetyltaxol. Rhone-Poulenc Sante, US Patent 4857653 (priority date: 17 July 1986).
  • FOGH, J. and KRIPKE, M. L., 1975, Human Tumour Cells in Vitro (New York: Plenum Press).
  • GUERITTE-VOEGELEIN, F., GUENARD, D., LAVELLE, F., LEGOFF, M. T., M ANGATAL, L. and POTIER, P., 1991, Relationships between structure of taxol analogues and their antimitotic activity. Journal of Medicinal Chemistry, 34, 992-998.
  • HALDAR, S., BASU, A. and CROCE, C. M., 1997, BcI 2 is the guardian of microtubule integrity. Cancer Research, 57, 229-233.
  • HENNEQUIN, C., GIOCANTI, N. and FAVAUDON; V., 1996, Interaction of ionising radiation with paclitaxel (taxol) and docetaxel (taxotere) in HeLa and SQ20B cells. Cancer Research, 56, 1842-1850.
  • HILL, B.T.,WHELAN, R. D. H., SHELLARD,S.A.and MCCLEAN, S., 1992, Differential cytotoxic effects of taxotere in a range of mammalian tumour cell lines in vitro. Annals of Oncology, 3, 120.
  • INGRAM, M. L. and REDPATH, J. L., 1997, Sub-additive interaction of radiation and taxol in vitro. International Journal of Radiation Oncology, Biology, Physics, 37, 1139-1144.
  • KARANTANIS, E., NICHOLSON, S. and MORRIS, D. L., 1994, Taxotere inhibits in vitro growth of human colonie cancer cell lines. European Journal of Surgical Oncology, 20, 653-657.
  • KAVANAGH, J. J., KUDELKA, A. P. and FREEDMAN, R. S., 1993, A phase II trial of taxotere in ovarian cancer patients already refractory to cisplatin/carboplatin therapy. Proceedings of the American Society of Clinical Oncology, 12, 259.
  • LEIBOVITZ, A., STINSON, J. C., McCOMBS, W. B, MCCOY, C. E., MAZUR, K. C. and MARBY, N. D., 1976, Classification of human colorectal adenocarcinoma cell lines. Cancer Research, 36, 4562-4569.
  • LJEBMANN, J., COOK, J. A., FISHER, J., TEAGUE, D. and MITCHELL, J. B., 1994, In vitro studies of taxol as a radiation sensitizer in human tumor cells. Journal of the National Cancer Institute, 86, 441-446.
  • MOTHERSILL, C. and SEYMOUR C. B., 1997, Survival of human epithelial cells irradiated with Cobalt 60 as microcolonies or single cells. International Journal of Radiation Biology, 72, 597-606.
  • PUCK, T. T. and MARCUS, P. L, 1956, Action of X-rays on mammalian cells. Journal of Experimental Medicine, 103, 653-666.
  • RINGEL, I. and HORWITZ, S. B., 1991, Studies with RP56976 (Taxotere) a semi-synthetic analogue of taxol. Journal of the National Cancer Institute, 83, 288-291.
  • RIOU, J. F., NAUDIN, A. and LAVELLE, F., 1992, Effects of taxotere on murine and human tumor cell lines. Biochemical and Biophysical Research Communications, 187, 164-170.
  • SINCLAIR, W. K. and MORTON, R. A., 1966, X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiation Research, 29, 450-474.
  • STEREN, A., SEVIN, B. U., PERRAS, J., ANGIOLI, R., NGUYEN, H. N., GUERRA, L. and AVERETTE, H. E., 1992, Radiosensitisation by taxol of a human ovarian cancer cell line. Proceedings of the American Society of Clinical Oncology, 33, 552.
  • TALWAR, N. and REDPATH, J. L., 1997, Schedule dependence of the interaction of radiation and taxol in HeLa cells. Radiation Research, 148, 48-53.
  • TERASIMA, R. and TOLMACH, L. J., 1963, X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells. Science, 140, 490-492.
  • TISHLER, R. B, SCHIFF, P. B, GEARD, C. R. and HALL, E. J., 1992, Taxol: a novel radiation sensitiser. International Journal of Radiation Oncology, Biology, Physics, 22, 613-617.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.